Schedule 13D ownership disclosure
EPIRUS BIOPHARMACEUTICALS INC
Security class unavailable · CUSIP: 29428P107
Event date: 2014-07-15
Legacy cover-page extraction is best effort and may not include every reporting person.
- Filing-level shares
- 22,239,223
- Percent of class
- 17.2000%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0000903423-14-000439
- Form type
- SC 13D
- Filer
- EPIRUS Biopharmaceuticals, Inc.
- CIK
- CIK 1135906
- Filed
- Jul 25, 2014
- Reporting period
- Jul 15, 2014
- Description
- Schedule 13D beneficial ownership